Document Detail


Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
MedLine Citation:
PMID:  19938108     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Histopathological evaluation of the liver via biopsy remains the standard procedure for the diagnosis of both acute cellular rejection (ACR) and recurrent hepatitis C (RHC) after liver transplantation. Nevertheless, it is often difficult to diagnose ACR in hepatitis C virus-positive recipients because of changes in common and overlapping with RHC. The aim of this study was to identify potential target genes for ACR in recipients with RHC. We analyzed 22 liver biopsy samples obtained from 21 hepatitis C virus-positive recipients. The clinicopathological diagnosis based on biopsy examination was ACR-predominant with superimposed RHC in 9 samples (ACR group) and RHC without ACR (non-ACR group) in 13. Using oligonucleotide microarrays, we compared the transcriptional changes in the 2 groups and selected 2206 genes that were significantly modulated in ACR. We analyzed the regulatory networks in ACR with Ingenuity Pathway Analysis software, and we confirmed with quantitative real-time polymerase chain reaction the reproducibility of caspase 8, apoptosis-related cysteine peptidase and bone morphogenetic protein 2 up-regulation in another group of validation samples, representing 2 genes from the core network as the target genes for ACR. Our results demonstrated novel transcriptome patterns for ACR with concurrent RHC that were distinct from those of recipients with only RHC, suggesting that gene expression profiling may be useful in the diagnosis of ACR in recipients with hepatitis C.
Authors:
Tadafumi Asaoka; Tomoaki Kato; Shigeru Marubashi; Keizo Dono; Naoki Hama; Hidenori Takahashi; Shogo Kobayashi; Yutaka Takeda; Ichiro Takemasa; Hiroaki Nagano; Hideo Yoshida; Phillip Ruiz; Andreas G Tzakis; Kenichi Matsubara; Morito Monden; Yuichiro Doki; Masaki Mori
Related Documents :
12665258 - The 2001 veylien henderson award of the society of toxicology of canada. positive and n...
20403458 - Multiple genes for functional 6 fatty acyl desaturases (fad) in atlantic salmon (salmo ...
16177188 - Fatty acids induce l-cpt i gene expression through a pparalpha-independent mechanism in...
9634038 - Gene expression of prothrombin in the human kidney and its potential relevance to kidne...
3020688 - Synchronized rearrangement of t-cell gamma and beta chain genes in fetal thymocyte deve...
3321068 - Constitutive expression of the yeast hem1 gene is actually a composite of activation an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society     Volume:  15     ISSN:  1527-6473     ISO Abbreviation:  Liver Transpl.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-30     Completed Date:  2010-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100909185     Medline TA:  Liver Transpl     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1738-49     Citation Subset:  IM    
Affiliation:
Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Aged
Biopsy
Bone Morphogenetic Protein 2 / genetics
Caspase 8 / genetics
Female
Gene Expression Profiling / methods*
Gene Expression Regulation
Gene Regulatory Networks
Genetic Testing*
Graft Rejection / diagnosis,  genetics*,  immunology,  virology
Hepatitis C / complications,  diagnosis,  genetics,  surgery*
Humans
Liver Transplantation / adverse effects*
Male
Middle Aged
NFATC Transcription Factors / genetics
Oligonucleotide Array Sequence Analysis*
Predictive Value of Tests
Receptor, Interferon alpha-beta / genetics
Receptors, Interleukin-12 / genetics
Recurrence
Reproducibility of Results
Reverse Transcriptase Polymerase Chain Reaction
Treatment Outcome
Chemical
Reg. No./Substance:
0/BMP2 protein, human; 0/Bone Morphogenetic Protein 2; 0/IFNAR1 protein, human; 0/IL12RB2 protein, human; 0/NFATC Transcription Factors; 0/NFATC3 protein, human; 0/Receptors, Interleukin-12; 156986-95-7/Receptor, Interferon alpha-beta; EC 3.4.22.-/CASP8 protein, human; EC 3.4.22.-/Caspase 8

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Next Document:  Expression of lymphatic markers during avian and mouse cardiogenesis.